Voraxaze 1000 UNT Injection
- RxCUI
- 1242136
- RxNorm name
- Voraxaze 1000 UNT Injection
- Display name
- Voraxaze 1000 UNT Injection
- Full name
- Voraxaze 1000 UNT Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:15
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125327 | Voraxaze | glucarpidase | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Voraxaze | GLUCARPIDASE | BTG International Inc. | acaef5a6-b740-40e3-8ffe-74a75c74745c | 2024-11-27 | Warnings, Adverse reactions | 1242136 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| acaef5a6-b740-40e3-8ffe-74a75c74745c | Voraxaze 1000 UNT Injection | PSN | 10 | These highlights do not include all the information needed to use VORAXAZE ® safely and effectively. See full prescribing information for VORAXAZE ® . VORAXAZE (glucarpidase) for injection, for intravenous use Initial U.S. Approval: 2012 | 20241127 |
| acaef5a6-b740-40e3-8ffe-74a75c74745c | glucarpidase 1000 UNT Injection [Voraxaze] | SBD | 10 | These highlights do not include all the information needed to use VORAXAZE ® safely and effectively. See full prescribing information for VORAXAZE ® . VORAXAZE (glucarpidase) for injection, for intravenous use Initial U.S. Approval: 2012 | 20241127 |
| acaef5a6-b740-40e3-8ffe-74a75c74745c | Voraxaze 1000 UNT Injection | SY | 10 | These highlights do not include all the information needed to use VORAXAZE ® safely and effectively. See full prescribing information for VORAXAZE ® . VORAXAZE (glucarpidase) for injection, for intravenous use Initial U.S. Approval: 2012 | 20241127 |